Biotech Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 February 12, 2025
Biotech dsm-firmenich to sell stake in Feed Enzymes Alliance to its partner Novonesis for €1.5 billion February 11, 2025
Biotech Government of Canada invests $6 million to drive growth in B.C.’s life sciences sector February 10, 2025
Biotech Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025 February 8, 2025
Biotech Accord Healthcare: Hetronifly® (Serplulimab) receives Marketing Authorisation from the European Commission (EC), for the treatment of Extensive-Stage Small Cell Lung Cancer (ES- SCLC) February 7, 2025
Biotech Akribion Therapeutics exits from stealth with €8m seed financing to pioneer RNA-guided, programmable cell depletion February 4, 2025
Biotech Fapon at Medlab Middle East 2025: Advancing Local Diagnostic Industry through One-stop IVD Solutions February 3, 2025